Antiepileptic drugs in the treatment of neuropathic pain

被引:95
作者
Eisenberg, Elon
River, Yaron
Shifrin, Ala
Krivoy, Norberto
机构
[1] Rambam Med Ctr, Pain Relief Unit, Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[3] Bnei Zion Med Ctr, Dept Neurol, Haifa, Israel
[4] Rambam Med Ctr, Dept Neurol, Haifa, Israel
[5] Rambam Med Ctr, Div Med, Clin Pharmacol Unit, Haifa, Israel
关键词
D O I
10.2165/00003495-200767090-00003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antiepileptic drugs are an effective treatment for various forms of neuropathic pain of peripheral origin, although they rarely provide complete pain relief. Multiple multicentre randomised controlled trials have shown clear efficacy of gabapentin and pregabalin for postherpetic neuralgia and painful diabetic neuropathy. Theses drugs can be rapidly titrated and are well tolerated. Topiramate, lamotrigine, carbamazepine and oxcarbazepine are alternatives for the treatment of painful diabetic neuropathy, but should be titrated slowly. Carbamazepine remains the drug of choice for trigeminal neuralgia; however, oxcarbazepine and lamotrigine are potential alternatives. There is an apparent need for large-scale randomised controlled trials on the efficacy of antiepileptic drugs in neuropathic pain in general, and in cancer-related neuropathic pain and neuropathic pain of central origin in particular. Trials with long-term follow-up are required to establish the long-term efficacy of antiepileptic drugs in neuropathic pain. There is only limited scientific evidence to support the idea that drug combinations are likely to be more efficacious and safer than each drug alone; further studies are warranted in this area.
引用
收藏
页码:1265 / 1289
页数:25
相关论文
共 129 条
[1]   The safety and effectiveness of newer antiepileptics: A comparative postmarketing cohort study [J].
Acharya, NV ;
Pickering, RM ;
Wilton, LW ;
Shakir, SAW .
JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (04) :385-393
[2]  
Anderson GD, 2001, FORMULARY, V36, P114
[3]   GABAPENTIN - A NEW AGENT FOR THE MANAGEMENT OF EPILEPSY [J].
ANDREWS, CO ;
FISCHER, JH .
ANNALS OF PHARMACOTHERAPY, 1994, 28 (10) :1188-1196
[4]   Pregabalin add-on treatment: A randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures [J].
Arroyo, S ;
Anhut, H ;
Kugler, AR ;
Lee, CM ;
Knapp, LE ;
Garofalo, EA ;
Messmer, S .
EPILEPSIA, 2004, 45 (01) :20-27
[5]   Zonisamide in the treatment of painful diabetic neuropathy: A randomized, double-blind, placebo-controlled pilot study [J].
Atli, A ;
Dogra, S .
PAIN MEDICINE, 2005, 6 (03) :225-234
[6]   Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial [J].
Backonja, M ;
Beydoun, A ;
Edwards, KR ;
Schwartz, SL ;
Fonseca, V ;
Hes, M ;
LaMoreaux, L ;
Garofalo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1831-1836
[7]   Lamotrigine plasma concentrations in children and adults: Influence of age and associated therapy [J].
Battino, D ;
Croci, D ;
Granata, T ;
Estienne, M ;
Pisani, F ;
Avanzini, G .
THERAPEUTIC DRUG MONITORING, 1997, 19 (06) :620-627
[8]  
Beydoun A, 2002, NEUROLOGY, V58, pA471
[9]  
Beydoun A, 2002, NEUROLOGY, V58, pA131
[10]   Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy [J].
Beyreuther, Bettina ;
Callizot, Noelle ;
Stoehr, Thomas .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 539 (1-2) :64-70